General
South Africa to suspend rollout of AstraZeneca coronavirus vaccine
South Africa was set to suspend the rollout of the AstraZeneca vaccine after trial data showed the jab offered limited protection against mild disease caused by B.1.351, the coronavirus variant first identified in the country.
Key points:
- Early data from an Oxford University study suggested the AstraZeneca vaccine offered only “minimal protection” against the South Africa variant
- Vaccine lead researcher Sarah Gilbert said the company expected to have a new jab to cope with the variant by September
- Federal Health Minister Greg Hunt said he was not concerned about vaccine
Early data from an Oxford University study suggested the AstraZeneca vaccine offered only “minimal protection” against mild disease caused by the South Africa variant.
But the…
-
Noosa News17 hours agoReubhan Ralph identified as man behind terrifying childcare centre incident in Peregian Springs on the Sunshine Coast
-
General15 hours agoPolice say new leads being pursued after baby’s body found in Alexander Heights stormwater drain
-
General23 hours agoQueensland announced as 2027 Women’s Softball World Cup host in first Australian event since 1965
-
Noosa News19 hours agoWomen’s Softball World Cup 2027 Redcliffe Brisbane